MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF

MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1

(2016) J Lu et al.   ONCOGENE

In vivo delivery of miRNAs for cancer therapy: Challenges and strategies

(2015) Yunching Chen et al.   ADVANCED DRUG DELIVERY REVIEWS

CD133 + melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: Significance for melanoma treatment

(2015) Abdelouahid El-Khattouti et al.   CANCER LETTERS

Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma

(2015) Cheolhee Won et al.   HEPATOLOGY

Clinical and biological significance of stem-like CD133 + CXCR4 + cells in esophageal squamous cell carcinoma

(2015) Chunlai Lu et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment

(2015) F J Kohlhapp et al.   ONCOGENE

Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy

(2015) Wen Wen Xu et al.   Oncotarget

Id1-Induced IGF-II and Its Autocrine/Endocrine Promotion of Esophageal Cancer Progression and Chemoresistance--Implications for IGF-II and IGF-IR-Targeted Therapy

(2014) B. Li et al.   CLINICAL CANCER RESEARCH

A CD90+ Tumor-Initiating Cell Population with an Aggressive Signature and Metastatic Capacity in Esophageal Cancer

(2013) K. H. Tang et al.   CANCER RESEARCH

RNAi Therapeutics and Applications of MicroRNAs in Cancer Treatment

(2013) Keita Uchino et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Oesophageal carcinoma

(2013) Arjun Pennathur et al.   LANCET

MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells

(2013) P Ceppi et al.   ONCOGENE

Roles of microRNAs during prostatic tumorigenesis and tumor progression

(2013) Y-X Fang et al.   ONCOGENE

MicroRNAs and cancer stem cells: the sword and the shield

(2013) X Sun et al.   ONCOGENE

Tumour angiogenesis regulation by the miR-200 family

(2013) Chad V. Pecot et al.   Nature Communications

Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Esophageal Cancer: A Systematic Review and Meta-analysis

(2012) M. Chen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma

(2012) D. Hang et al.   DISEASES OF THE ESOPHAGUS

Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization

(2012) Virginia Tirino et al.   FASEB JOURNAL

MicroRNAs in Pathogenesis, Diagnosis, and Treatment of Gastroesophageal Cancers

(2012) Jee Hoon Song et al.   GASTROENTEROLOGY

Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury

(2012) Matthew Campbell et al.   Nature Communications

MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma

(2011) A. F. Ibrahim et al.   CANCER RESEARCH

Nucleostemin and TWIST as predictive markers for recurrence after neoadjuvant chemotherapy for esophageal carcinoma

(2011) Takako E. Nakajima et al.   CANCER SCIENCE

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

5′ Triphosphorylated Small Interfering RNAs Control Replication of Hepatitis B Virus and Induce an Interferon Response in Human Liver Cells and Mice

(2011) Gregor Ebert et al.   GASTROENTEROLOGY

CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling

(2011) Kwan Ho Tang et al.   HEPATOLOGY

Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44

(2011) Jiang-Sha Zhao et al.   PLoS One

Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor

(2010) Daniel King Hung Tong et al.   ANNALS OF SURGICAL ONCOLOGY

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Overexpression of CD133 promotes the phosphorylation of Erk in U87MG human glioblastoma cells

(2010) Lin Dong et al.   NEUROSCIENCE LETTERS

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

MicroRNAs and Cancer: Short RNAs Go a Long Way

(2009) Andrea Ventura et al.   CELL

Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31

(2009) Florian Haller et al.   JOURNAL OF PATHOLOGY

Targeting NF- B signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer

(2009) B. Li et al.   MOLECULAR CANCER THERAPEUTICS

MicroRNAs: key regulators of stem cells

(2009) Vamsi K. Gangaraju et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

MicroRNAs as potential cancer therapeutics

(2009) P Trang et al.   ONCOGENE

5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma

(2008) Hendrik Poeck et al.   NATURE MEDICINE